Physician profile
David D Lam
NPI 1841828647
$3,608.78
in general payments reported to CMS, 2019-2025
14 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $458 · 2023: $404 · 2024: $1,683 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,976 · Travel and Lodging: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,976.19 |
| Travel and Lodging | $1,174.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,458.30 | 2022-2025 | Scopis Ent, Na, Vsp System, Vsp Cranial |
| Inspire Medical Systems, INC. | $1,146.42 | 2024 | Inspire |
| Genzyme Corporation | $164.41 | 2023-2025 | |
| Integra Lifesciences Corporation | $150.97 | 2022-2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Med-El Corporation | $136.37 | 2023 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit |
| Regeneron Healthcare Solutions, INC. | $127.65 | 2024 | Dupixent |
| Baxter Healthcare | $109.21 | 2025 | Floseal |
| Polynovo North America LLC | $83.37 | 2024 | Novosorb Btm |
| Ionis Pharmaceuticals, INC. | $69.76 | 2025 | Dawnzera |
| Glaxosmithkline, LLC. | $46.82 | 2025 | Nucala |
| Axogen | $45.05 | 2025 | |
| Csl Behring | $28.90 | 2025 | Andembry |
| Karl Storz Endoscopy-America | $25.11 | 2024 | N.A. |
| Olympus America INC. | $16.44 | 2023 | Rhino-Laryngo Videoscope, Hd Camera Head |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.